PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.\', \'Clinical Immunology and Allergy, Department of Medicine, McGill University Health Center, MontrĂ©al, QC, Canada.\', \'The Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada.\', \'Department of Medicine, St Vincent\'s Hospital, University of Melbourne, Fitzroy, VIC, Australia.\', \'Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.\', \'Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC, Australia.\', \'Department of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.\', \'Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia.\', \'The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.646095
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33815405
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all